Memorial Sloan Kettering Cancer Center 9th Annual State-of-the-Art in Thrombosis and Hemostasis Symposium 2020
Format:6 videos + 8 pdfs, size: 3.27 GB
Course Audience: hematology/oncology practitioners, fellows, advanced practice providers
Overview:
Date & LocationSunday, October 18, 2020, 8:45 AM – 4:45 PM EST
SpecialtiesSpecialties – Hematology, Oncology and HematologyOverviewThis course is designed to provide an important annual educational forum for Hematology and Oncology doctors. The ultimate objective of this activity is to enhance physician understanding of the disease state and treatment advances for the benefit of patients.
The target audience for this symposium includes hematology/oncology practitioners, fellows, advanced practice providers and other healthcare professionals in the field.
2020 Symposium Topics
- New Innovations in Bleeding Disorders
- New Innovations on Thrombotic Disorders
- The COVID19-Related Coagulopathy – Pathophysiology and Management
- Thrombotic Microangiopathy
- Platelet Focus Symposium
- Thrombocytopenia (Not all thrombocytopenia is ITP)
- Immune Thrombocytopenic Purpura
- Chemotherapy-Induced Thrombocytopenia
Case Discussion / Request for Case Submissions
When you register, you will have an opportunity to submit a case for discussion during the course. Case discussions will be held at the end of the day. In order to prepare your submission, we ask that you provide a BRIEF summary of your case and include key lab results. Please ensure that all identifiable PHI has been removed. Cases should have an educational purpose. The course faculty will not be able to provide a detailed/complex consult review during the course and they will try to get through as many cases as possible.
Objectives- Review the recent scientific updates in the diagnosis and management of hemorrhagic disorders.
- Review the recent scientific updates in the diagnosis and management of thrombotic disorders.
- Review the recent scientific updates in the area of platelet disorders, including Immune Thrombocytopenic Purpura, Chemotherapy-Induced Thrombocytopenia, Thrombotic Microangiopathy, and anti-platelet therapy.
Chemotherapy-Induced Thrombocytopenia (Video MP4 Format)
Chemotherapy-Induced Thrombocytopenia (PDF Format)Immune Thrombocytopenic Purpura (Video MP4 Format)Immune Thrombocytopenic Purpura (PDF Format)New Innovations in Bleeding Disorders (Video MP4 Format)New Innovations in Bleeding Disorders (PDF Format)New Innovations on Thrombotic Disorders (PDF Format)The COVID19-Related Coagulopathy – Pathophysiology and Management (Video MP4 Format)The COVID19-Related Coagulopathy – Pathophysiology and Management (PDF Format)Thrombocytopenia (Not All Thrombocytopenia is ITP) (Video MP4 Format)Thrombocytopenia (Not All Thrombocytopenia is ITP) (PDF Format)Thrombosis2020_Brochure (PDF Format)Thrombotic Microangiopathy (Video MP4 Format)Thrombotic Microangiopathy (PDF Format)